Evidence map›Paper›PMID 34086706›Full record

Trial reportPloS one2021

Smokers' cognitive and behavioural reactions during the early phase of the COVID-19 pandemic: Findings from the 2020 ITC Four Country Smoking and Vaping Survey.

Shannon Gravely, Lorraine V Craig, K Michael Cummings, Janine Ouimet, Ruth Loewen, Nadia Martin, Janet Chung-Hall, Pete Driezen, Sara C Hitchman, Ann McNeill and 7 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model.Canadian journal of public health = Revue canadienne de sante publique · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Associations between Tobacco Use, Surges, and Vaccination Status over Time in the COVID-19 Era.International journal of environmental research and public health · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shannon GravelyDepartment of Psychology, University of Waterloo, Waterloo, Canada.ORCID 0000-0001-5224-9105
Lorraine V CraigDepartment of Psychology, University of Waterloo, Waterloo, Canada.
K Michael CummingsDepartment of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States of America.
Janine OuimetDepartment of Psychology, University of Waterloo, Waterloo, Canada.
Ruth LoewenDepartment of Psychology, University of Waterloo, Waterloo, Canada.
Nadia MartinDepartment of Psychology, University of Waterloo, Waterloo, Canada.
Janet Chung-HallDepartment of Psychology, University of Waterloo, Waterloo, Canada.
Pete DriezenDepartment of Psychology, University of Waterloo, Waterloo, Canada.
Sara C HitchmanDepartment of Addictions, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.
Ann McNeillDepartment of Addictions, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.
Andrew HylandDepartment of Health Behaviour, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America.
Anne C K QuahDepartment of Psychology, University of Waterloo, Waterloo, Canada.
Richard J O'ConnorDepartment of Health Behaviour, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America.
Ron BorlandSchool of Psychological Sciences, Melbourne Centre for Behaviour Change, University of Melbourne, Melbourne, Australia.
Mary E ThompsonDepartment of Statistics and Actuarial Science, University of Waterloo, Waterloo, Canada.
Christian BoudreauDepartment of Statistics and Actuarial Science, University of Waterloo, Waterloo, Canada.
Geoffrey T FongDepartment of Psychology, University of Waterloo, Waterloo, Canada.

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FONG, GEOFFREY T · 2016 to 2025
$25.3M
NCI NIH HHS P01 CA200512
6 · The paper itself

Abstract

introductionCOVID-19 is primarily a respiratory illness, and smoking adversely impacts the respiratory and immune systems; this confluence may therefore incentivize smokers to quit. The present study, conducted in four high-income countries during the first global wave of COVID-19, examined the association between COVID-19 and: (1) thoughts about quitting smoking; (2) changes in smoking (quit attempt, reduced or increased smoking, or no change); and (3) factors related to a positive change (making a quit attempt or reducing smoking) based on an adapted framework of the Health Belief Model.

methodsThis cross-sectional study included 6870 adult smokers participating in the Wave 3 (2020) ITC Four Country Smoking and Vaping Survey conducted in Australia, Canada, England, and United States (US). These four countries had varying responses to the pandemic by governments and public health, ranging from advising voluntary social distancing to implementing national and subnational staged lockdowns. Considering these varying responses, and the differences in the number of confirmed cases and deaths (greatest in England and the US and lowest in Australia), smoking behaviours related to COVID-19 may have differed between countries. Other factors that may be related to changes in smoking because of COVID-19 were also explored (e.g., sociodemographics, nicotine dependence, perceptions about personal and general risks of smoking on COVID-19). Regression analyses were conducted on weighted data.

resultsOverall, 46.7% of smokers reported thinking about quitting because of COVID-19, which differed by country (p<0.001): England highest (50.9%) and Australia lowest (37.6%). Thinking about quitting smoking because of COVID-19 was more frequent among: females, ethnic minorities, those with financial stress, current vapers, less dependent smokers (non-daily and fewer cigarettes smoked/day), those with greater concern about personal susceptibility of infection, and those who believe COVID-19 is more severe for smokers. Smoking behaviour changes due to COVID-19 were: 1.1% attempted to quit, 14.2% reduced smoking, and 14.6% increased smoking (70.2% reported no change). Positive behaviour change (tried to quit/reduced smoking) was reported by 15.5% of smokers, which differed by country (p = 0.02), where Australia had significantly lower rates than the other three countries. A positive behavioural smoking change was more likely among smokers with: lower dependence, greater concern about personal susceptibility to infection, and believing that COVID-19 is more severe for smokers.

conclusionsThough nearly half of smokers reported thinking about quitting because of COVID-19, the vast majority did not change their smoking behaviour. Smokers were more likely to try and quit or reduce their smoking if they had greater concern about susceptibility and severity of COVID-19 related to smoking. Smokers in Australia were least likely to reduce or try to quit smoking, which could be related to the significantly lower impact of COVID-19 during the early phase of the pandemic relative to the other countries.

Indexed as

CognitionHealth BehaviorSARS-CoV-2SmokersSmoking CessationSurveys and QuestionnairesAdolescentAdultCOVID-19Cross-Sectional StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedTobacco Smoking

Identifiers

PMID34086706
PMCPMC8177641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.